期刊文献+

NF-kB在加贝酯对大鼠肝缺血再灌注损伤过程中的活化及意义 被引量:4

Effect of gabexate mesilate on activation of nuclear factor kappa B during hepatic ischemia reperfusion injury in rats
暂未订购
导出
摘要 目的探讨加贝酯及核因子(NF-κB)在肝缺血再灌注损伤中的作用。方法采用Pringle’s法建立大鼠肝脏缺血再灌注模型,将40只SD大鼠随机分成四组,每组10只:假手术组(A组)、缺血再灌注组(B组)、加贝酯处理组(C组)、盐水对照组(D组)。光镜观察肝脏组织学变化,分别测定血浆中天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)及组织中髓过氧化物酶(MPO)含量;并采用SABC免疫组化法观察肝组织中NF-κB的变化。结果 :A组肝组织形态正常,无NF-κB活化,肝功能酶学和MPO正常水平;B、D组肝细胞索排列紊乱,肝小叶变形,肝细胞和内皮细胞普遍水肿变性,中央区局灶性肝细胞坏死,汇管区中性粒细胞浸润,血窦内微血栓形成,NF-kB活化最为明显,血清酶学和MPO升高最为显著(P<0.01);C组能明显减轻这种损伤,NF-κB呈中度活化。结论肝缺血再灌注时,NF-κB被活化,使中性粒细胞向组织浸润,对肝脏缺血再灌注损伤起着重要的作用。 【Objective】To investigate the effect of gabexate mesilate(GM) and NF-κB on hepatic ischemia reperfusion injury in rats.【Methods】Models of rats with hepatic ischemia reperfusion injury were established with the Pringle's method.Forty SD rats were randomly divided into four groups: normal control group(group A),model group(group B),gabexate mesilate group(group C) and saline group(group D).Plasma alanine aminotransferase(ALT),aspartate aminotransferase(AST) and myeloperoxidase(MPO) in liver tissue were respectively measured in each group.The activity of NF-κB was determined by sABC immunohistochemistry,also histological examination of the liver was made.【Results】In group A,the histological test,ALT,AST and MPO were almost normal,NF-kB didn't have activity.In group B and D,hepatocytes were arranged in turbulence,hepatic lobules were distorted,hepatocytes and endothelial cells underwent swelling or necrosis,and neutrophils infiltrated in portal area,congestion and micro-thrombosis appeared in liver sinusoids;the activity of ALT,AST,MPO and NF-kB increased remarkably(P 0.01);but the injury was markedly decreased in rats pretreated with GM.【Conclusion】Nuclear factor kappa B is involved and may play an important role in liver ischemic reperfusion injury.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第6期821-823,共3页 China Journal of Modern Medicine
基金 湖南省科学技术厅一般项目(No:2008FJ3058)
关键词 缺血再灌注 肝脏 核因子-ΚB 加贝酯 ischemic reperfusion injury liver NF-κB gabexate mesilate
  • 相关文献

参考文献3

二级参考文献34

  • 1杨宁,许红波,李兆申,许国铭.生长抑素类似物奥曲肽的临床应用[J].新药与临床,1994,13(1):31-33. 被引量:50
  • 2Jalan R.Acute liver failure:current management and future prospects[J].J Hepatology,2005,(42s):115-123.
  • 3Ravikumar V,Shivashangari KS,Devaki T.Effect of Tridax procumbens on liver antioxidant defense system during lipopolysaccharide-induced hepatitis in D-galactosamine sensitised rats[J].Mol Cell Biochem,2005,269 (1/2):131-136.
  • 4Soriano ME,Nicolosi L,Bernardi P.Desensitization of the permeability transition pore by cyclosporin a prevents activation of the mitochondrial apoptotic pathway and liver damage by tumor necrosis factor-alpha[J].J Biol Chem,2004,279 (35):36803-36808.
  • 5Tamaki S,Wada H,Hiyoyama K,et al.Treatment of disseminated intravascular coagulation with gabexate mesilate[J].Clin Ther,1993,15 (6):1076-1084.
  • 6Murakami K,Okajima K,Uchiba M,et al.Gabexate mesilate,a synthetic protease inhibitor,attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes[J].Crit Care Med,1996,24 (6):1047-1053.
  • 7Harada N,Okajima K,Kushimoto S.Gabexate mesilate,a synthetic protease inhibitor,reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation[J].Crit Care Med,1999,27 (9):1958-1964.
  • 8Jung SE,Yun IJ,Youn YK,et al.Effect of protease inhibitor on ischemia-reperfusion injury to rat liver[J].World J Surg,1999,23(10):1027-1031.
  • 9Kim YI,Hwang YJ,Song KE,et al.Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver[J].J Am Coll Surg,2002,195 (1):41-50.
  • 10Yuksel M,Okajima K,Uchiba M,et al.Gabexate mesilate,a synthetic protease inhibitor,inhibits lipopolysaccharide-induced tumor necrosis factor-α production by inhibiting activation of both nuclear factor-κB and activation protein-1 in human monocytes[J].J Pharmacol Exp Ther,2003,305 (1):298-305.

共引文献22

同被引文献43

  • 1赵中江,孙冀武,邓哲.不同方式液体复苏对失血性休克大鼠外周血单个核细胞中核转录因子-κB活性的影响[J].中国危重病急救医学,2007,19(5):299-302. 被引量:10
  • 2Helling H,Schenk HJ,Pindur G,et al.Fibrinolytic and procoagulant activity in septic and haemorrhagic shock[J].Clin Hemorheol Microcirc,2010,45(2-4):295-300.
  • 3Liu SE,Malik AB.NF-κB activation as a pathological mechanism of septic shock and inflammation[J].Am J Physiol Lung Cell Mol Physiol,2006,290(4):L622-L645.
  • 4Kaczorowski DJ,Nakao A,Vallabaneni R,et al.Mechanisms of Toll-like receptor 4 (TLR4) mediated inflammation after cold ischemia/reperfusion in the heart[J].Transplantation,2009,87(10):1455-1463.
  • 5B rasier AR.The NF-kappaB regulatory network[J].Cardiovasc Toxicol,2006,6 (2):111-130.
  • 6Kulms D,Schwarz T.NF-kappaB and cytokines[J].V itam Horm,2006,74 (1):283-300.
  • 7Sharif O,Bolshakov VN,Raines S,et al.Transcriptional profiling of the LPS induced NF-kappaB response in macrophages[J].BMC Immunol,2007,12 (8):1.
  • 8Brundage SI,Schreiber MA,Holcomb JB,et al.Amplification of the proinflammatory transcription factor cascade increases with severity of uncontrolled hemorrhage in swine[J].J Surg Res,2003,113(1):74-80.
  • 9Zhong C,Zhou Y,Liu H.Nuclear factor-κB and anesthetic preconditioning during myocardial ischemia reperfusion[J].Anesthesiology,2004,100(3):540-546.
  • 10姚咏明,黄立锋.《2008国际严重脓毒症和脓毒性休克治疗指南》概要[J].中国危重病急救医学,2008,20(3):135-138. 被引量:83

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部